Carcinogenesis
Adverse events and recent advances in CAR-T-cell therapy.
Zhimin Bai, Xiaoyu Huang, Hui Jia, Zenghua Lin, Hong Liu
Published: 202510.1093/carcin/bgaf083
Abstract
Chimeric antigen receptor (CAR-T) cell therapy has been widely used in haematological malignancies and has achieved remarkable results. However, two major toxicities of CAR-T-cell therapy, cytokine release syndrome (CRS) and immune effector cell-asso…
Preview only. Read the full abstract at the source